What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Diabetes mellitus
His primary scientific interests are in Risk factor, Internal medicine, Body mass index, Blood pressure and Surgery.
His study in Risk factor is interdisciplinary in nature, drawing from both Epidemiology, Relative risk, Stroke, Proportional hazards model and Prospective cohort study.
The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Endocrinology.
His Endocrinology research is multidisciplinary, incorporating elements of Quantitative trait locus, Genome-wide association study and Genetic association.
His Body mass index research includes elements of Genetics, Physical exercise and Obesity.
His Surgery research integrates issues from Cohort study and Confidence interval.
His most cited work include:
- Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index (2348 citations)
- Six new loci associated with body mass index highlight a neuronal influence on body weight regulation (1434 citations)
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. (1180 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Risk factor, Body mass index, Blood pressure and Epidemiology.
His Internal medicine research focuses on Diabetes mellitus and how it relates to Incidence.
His studies deal with areas such as Coronary heart disease, Logistic regression, Surgery, Relative risk and Public health as well as Risk factor.
The Body mass index study combines topics in areas such as Genetics and Obesity.
His studies in Blood pressure integrate themes in fields like Cross-sectional study, Physical therapy, Disease and Heart failure.
His Epidemiology study combines topics in areas such as Gerontology, Cohort study and Environmental health.
He most often published in these fields:
- Internal medicine (35.64%)
- Risk factor (17.06%)
- Body mass index (15.77%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (35.64%)
- Disease (7.78%)
- Hazard ratio (11.02%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Disease, Hazard ratio, Obesity and Cardiology.
Pekka Jousilahti interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
His studies in Disease integrate themes in fields like Liver disease, Genetics, Mendelian randomization and Genome-wide association study.
Pekka Jousilahti works mostly in the field of Hazard ratio, limiting it down to concerns involving Proportional hazards model and, occasionally, Renal function, Kidney disease, Cystatin C and Testosterone.
His Obesity study incorporates themes from Diabetes mellitus and Large cohort.
His Waist research is multidisciplinary, relying on both Risk of death, Epidemiology, Incidence and Risk factor.
Between 2019 and 2021, his most popular works were:
- Genome-wide Association Analysis in Humans Links Nucleotide Metabolism to Leukocyte Telomere Length (17 citations)
- Taxonomic Signatures of Long-Term Mortality Risk in Human Gut Microbiota (16 citations)
- Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity (9 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Diabetes mellitus
Disease, Genetics, Internal medicine, Genome-wide association study and Mendelian randomization are his primary areas of study.
The concepts of his Genetics study are interwoven with issues in Fagerstrom Test for Nicotine Dependence and Addiction.
His Internal medicine research incorporates themes from Endocrinology, Methylation and Cardiology.
His research in Genome-wide association study intersects with topics in SLCO1B1, Mendelian Randomization Analysis, Metabolomics, Metabolite and Telomere.
His Mendelian randomization research includes themes of Cancer, Thyroid cancer, Genetic association and Medical genetics.
In Lipoprotein, Pekka Jousilahti works on issues like Hazard ratio, which are connected to Cholesterol, Apolipoprotein B, Diabetes mellitus, Coronary artery disease and Body mass index.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
